» Articles » PMID: 35265931

Risk Factor Management of Atrial Fibrillation Using MHealth: The Atrial Fibrillation - Helping Address Care with Remote Technology (AF-HEART) Pilot Study

Abstract

Background: Personalized treatment of atrial fibrillation (AF) risk factors using mHealth and telehealth may improve patient outcomes.

Objective: The purpose of this study was to assess the feasibility of the Atrial Fibrillation Helping Address Care with Remote Technology (AF-HEART) intervention on the following patient outcomes: (1) heart rhythm tracking; (2) weight, alcohol, blood pressure (BP), and sleep apnea reduction; (3) AF symptom reduction; and (4) quality-of-life (QOL) improvement.

Methods: A total of 20 patients with AF undergoing antiarrhythmic therapy, cardioversion, and/or catheter ablation were enrolled and followed for 6 months. The AF-HEART intervention included remote heart rhythm, weight, and BP tracking; televisits with a dietician focusing on AF risk factors; and referrals for sleep apnea and hypertension treatment.

Results: Patients transmitted a median of 181 rhythm recordings during the 6-month follow-up period. Patients lost an average of 3.5 kilograms at 6 months ( = .005). Patients had improved SF-12 scores ( = .01), AFSS score ( = .01), EQ-5D score ( = .006), and AFEQT Global Score ( = .03). There was significant correlation between weight loss and decrease in symptom severity (r = -0.45, = .05), and between % weight loss and decrease in symptom severity (r = -0.49, = .03).

Conclusion: This study described the feasibility of the AF-HEART intervention for (1) consistent remote tracking of heart rhythm, weight, and BP; (2) achievement of weight loss; (3) reduction of symptoms; and (4) improvement in QOL. Expansion to a larger randomized study is planned.

Citing Articles

Efficacy of an evidence-based telehealth-delivered weight-loss intervention to expand reach and enhance access to underserved groups after stroke.

McShan E, Alrawi S, Calhoun S, Gilliland T, Bennett M, Dubiel R Contemp Clin Trials Commun. 2025; 44:101458.

PMID: 40060240 PMC: 11889600. DOI: 10.1016/j.conctc.2025.101458.


Impact of lifestyle risk factors on atrial fibrillation: Mechanisms and prevention approaches - A narrative review.

Vermeer J, van den Broek J, Dekker L Int J Cardiol Cardiovasc Risk Prev. 2024; 23:200344.

PMID: 39534719 PMC: 11555354. DOI: 10.1016/j.ijcrp.2024.200344.


Smartphone application-based intervention to lower blood pressure: a systematic review and meta-analysis.

Abe M, Hirata T, Morito N, Kawashima M, Yoshida S, Takami Y Hypertens Res. 2024; 48(2):492-505.

PMID: 39396072 DOI: 10.1038/s41440-024-01939-6.


Factors Associated with Quality of Life among People with Atrial Fibrillation: Jordan Atrial Fibrillation Registry Study.

Al-Bashaireh A, Alkouri O, Alharbi A, Khader Y, Hammoudeh A, Aljawarneh Y Medicina (Kaunas). 2024; 60(8).

PMID: 39202543 PMC: 11356530. DOI: 10.3390/medicina60081262.


Atrial fibrillation: epidemiology, screening and digital health.

Linz D, Gawalko M, Betz K, Hendriks J, Lip G, Vinter N Lancet Reg Health Eur. 2024; 37:100786.

PMID: 38362546 PMC: 10866942. DOI: 10.1016/j.lanepe.2023.100786.

References
1.
Jongnarangsin K, Chugh A, Good E, Mukerji S, Dey S, Crawford T . Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2008; 19(7):668-72. DOI: 10.1111/j.1540-8167.2008.01118.x. View

2.
Takigawa M, Takahashi A, Kuwahara T, Takahashi Y, Okubo K, Nakashima E . Impact of Alcohol Consumption on the Outcome of Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation. J Am Heart Assoc. 2016; 5(12). PMC: 5210418. DOI: 10.1161/JAHA.116.004149. View

3.
Qiao Y, Shi R, Hou B, Wu L, Zheng L, Ding L . Impact of Alcohol Consumption on Substrate Remodeling and Ablation Outcome of Paroxysmal Atrial Fibrillation. J Am Heart Assoc. 2015; 4(11). PMC: 4845226. DOI: 10.1161/JAHA.115.002349. View

4.
Chan M, Esteve D, Fourniols J, Escriba C, Campo E . Smart wearable systems: current status and future challenges. Artif Intell Med. 2012; 56(3):137-56. DOI: 10.1016/j.artmed.2012.09.003. View

5.
Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers G . The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol. 2000; 36(4):1303-9. DOI: 10.1016/s0735-1097(00)00886-x. View